Katsuhito Miyazawa Selected Research

Chlormadinone Acetate (Chlormadinone)

1/2013	The effects of chlormadinone acetate on lower urinary tract symptoms and erectile functions of patients with benign prostatic hyperplasia: a prospective multicenter clinical study.
4/2011	[Changes in serum prostate specific antigen and testosterone levels after chlormadinone acetate treatment in patients with benign prostatic hyperplasia : a prospective multicenter clinical study].
5/2006	Prostate-specific antigen changes as a result of chlormadinone acetate administration to patients with benign prostatic hyperplasia: a retrospective multi-institutional study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katsuhito Miyazawa Research Topics

Disease

7	Urolithiasis 01/2019 - 12/2005
6	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 05/2006
4	Neoplasms (Cancer) 01/2020 - 01/2011
4	Urinary Calculi (Urinary Calculus) 03/2014 - 08/2004
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 02/2007
3	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2016
3	Carcinogenesis 09/2014 - 02/2007
3	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2013 - 05/2006
2	Inflammation (Inflammations) 01/2021 - 12/2005
2	Hyperoxaluria (Oxaluria) 01/2019 - 02/2005
2	Calculi (Calculus) 12/2012 - 12/2005
2	Kidney Calculi (Kidney Stone) 10/2011 - 02/2009
2	Renal Cell Carcinoma (Grawitz Tumor) 02/2011 - 02/2002
1	Lymphatic Metastasis 01/2020
1	Hypertension (High Blood Pressure) 01/2019
1	Infections 01/2019
1	Hypercalciuria 01/2019
1	Hernia (Hernias) 05/2018
1	Adenocarcinoma 09/2014
1	Hypoxia (Hypoxemia) 09/2014
1	Constipation 04/2014
1	Overactive Urinary Bladder (Overactive Bladder) 04/2014
1	Lower Urinary Tract Symptoms 01/2013
1	Nephrocalcinosis 10/2012
1	Lung Neoplasms (Lung Cancer) 03/2011
1	Death (Near-Death Experience) 01/2010
1	Ischemia 01/2010
1	Reperfusion Injury 01/2010
1	Angiomyolipoma 01/2008
1	Carcinoma (Carcinomatosis) 02/2007

Drug/Important Bio-Agent (IBA)

7	Calcium OxalateIBA 01/2019 - 02/2005
3	Prostate-Specific Antigen (Semenogelase)IBA 01/2019 - 05/2006
3	Proteins (Proteins, Gene)FDA Link 03/2014 - 08/2004
3	Chlormadinone Acetate (Chlormadinone)IBA 01/2013 - 05/2006
3	Androgen Antagonists (Antiandrogens)IBA 01/2013 - 05/2006
3	CalciumIBA 12/2012 - 04/2009
2	Ethylene Glycol (Monoethylene Glycol)IBA 01/2019 - 04/2009
2	Docetaxel (Taxotere)FDA Link 09/2017 - 03/2011
2	urocalunIBA 04/2009 - 12/2007
1	Febuxostat FDA Link 01/2021
1	Xanthine OxidaseIBA 01/2021
1	MucinsIBA 01/2020
1	Eplerenone (Inspra)FDA LinkGeneric 01/2019
1	alfacalcidolIBA 01/2019
1	Alkaline PhosphataseIBA 01/2019
1	C-Reactive ProteinIBA 01/2019
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2019
1	SaltsIBA 01/2019
1	NestinIBA 09/2014
1	Biomarkers (Surrogate Marker)IBA 09/2014
1	propiverineIBA 04/2014
1	oxybutynin (Tavor)FDA LinkGeneric 04/2014
1	Solifenacin Succinate FDA Link 04/2014
1	Tolterodine Tartrate (Detrol)FDA Link 04/2014
1	imidafenacinIBA 04/2014
1	Muscarinic AntagonistsIBA 04/2014
1	Calcium Carbonate (Limestone)FDA Link 03/2014
1	Progesterone FDA LinkGeneric 01/2013
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2012
1	Hyaluronic Acid (Hyaluronan)IBA 10/2012
1	ProstaglandinsIBA 10/2012
1	Testosterone (Sustanon)FDA Link 04/2011
1	Hormones (Hormone)IBA 03/2011
1	perfluorobutane (AI 700)IBA 02/2011
1	Indicators and Reagents (Reagents)IBA 01/2011
1	Biological ProductsIBA 01/2011
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2010
1	Erythropoietin FDA Link 01/2010
1	Cholecalciferol (Vitamin D3)FDA Link 04/2009
1	Complementary DNA (cDNA)IBA 02/2009
1	MART-1 AntigenIBA 01/2008
1	ButylhydroxybutylnitrosamineIBA 02/2007
1	CyclinsIBA 02/2007
1	Beta-CryptoxanthinIBA 02/2007
1	hydroxide ionIBA 02/2007
1	Drinking WaterIBA 02/2007
1	Oxalic Acid (Disodium Oxalate)IBA 12/2005
1	Prothrombin (Factor II)IBA 12/2005
1	FatsIBA 08/2004
1	OilsIBA 08/2004
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 02/2002
1	DNA (Deoxyribonucleic Acid)IBA 02/2002

Therapy/Procedure

5	Therapeutics 01/2020 - 01/2010
3	Drug Therapy (Chemotherapy) 09/2017 - 03/2011
2	Radiotherapy 01/2020 - 01/2016
2	Renal Dialysis (Hemodialysis) 02/2011 - 02/2002
1	Adjuvant Chemotherapy 01/2020
1	Stents 05/2018
1	Castration 09/2017
1	Brachytherapy 10/2012
1	Aftercare (After-Treatment) 04/2011
1	Combination Drug Therapy (Combination Chemotherapy) 03/2011
1	Microbubbles 02/2011
1	Chemoprevention 01/2011
1	Oral Administration 04/2009